A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is the most common cause of nasal polyposis, and approximately one third of patients with chronic rhinosinusitis (CRS) will develop nasal polyps. CRSwNP is associated with significant morbidity and negative impacts on patient quality of life, making rapid diagnosis and treatment highly important. Until recently, treatment for CRSwNP has included topical therapy, systemic corticosteroids, and surgery, with minimal efficacy and high morbidity. However, improved understanding of the pathophysiology of CRSwNP has led to the development of numerous biologic therapies that target the inflammatory pathways underlying disease pathogenesis. These agents are more effective and less toxic than historic treatments.

Share

Program Content

Activities

  • New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps
    A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 30, 2022

    Expires: September 30, 2023

Faculty

cover img faculity

Neil Skolnik, MD

Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Abington, Pennsylvania

cover img faculity

Eileen Wang, MD, MPH

Assistant Professor
Division of Allergy and Immunology
Department of Medicine
National Jewish Health
University of Colorado School of Medicine
Denver and Aurora, Colorado

Provided by

ProCE Banner
ProCE Banner

Jointly provided by PCME and Rockpointe.

Supporters

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Regeneron Pharmaceuticals, Inc

Sanofi